Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Xingtao Tian
Design, Synthesis, and Evaluation of Diarylpyridines and Diarylanilines as Potent Non-Nucleoside HIV-1 Reverse Transcriptase Inhibitors
Journal of Medicinal Chemistry
Drug Discovery
Molecular Medicine
Related publications
New Indolylarylsulfones as Highly Potent and Broad Spectrum HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors
European Journal of Medicinal Chemistry
Medicine
Organic Chemistry
Drug Discovery
Pharmacology
Mechanisms of Inhibition of HIV Replication by Non-Nucleoside Reverse Transcriptase Inhibitors
Virus Research
Cancer Research
Virology
Infectious Diseases
Synthesis of Alkenyldiarylmethanes (ADAMs) Containing Benzo[d]isoxazole and Oxazolidin-2-One Rings, a New Series of Potent Non-Nucleoside HIV-1 Reverse Transcriptase Inhibitors
European Journal of Medicinal Chemistry
Medicine
Organic Chemistry
Drug Discovery
Pharmacology
Structure-Based Evaluation of Non-Nucleoside Inhibitors With Improved Potency and Solubility That Target HIV Reverse Transcriptase Variants
Journal of Medicinal Chemistry
Drug Discovery
Molecular Medicine
Synthesis and Anti-Hiv-1 Activity Evaluation of 5-Alkyl-2-Alkylthio-6-(Arylcarbonyl or A-Cyanoarylmethyl)-3, 4-Dihydropyrimidin-4(3h)-Ones as Novel Non-Nucleoside HIV-1 Reverse Transcriptase Inhibitors
Multicenter Study of Skin Rashes and Hepatotoxicity in Antiretroviral-Naïve HIV-positive Patients Receiving Non-Nucleoside Reverse-Transcriptase Inhibitor Plus Nucleoside Reverse-Transcriptase Inhibitors in Taiwan
PLoS ONE
Multidisciplinary
Synthesis and Anti-Hiv Activity of Some [Nucleoside Reverse Transcriptase Inhibitor]-C5′-Linker-[Integrase Inhibitor] Heterodimers as Inhibitors of HIV Replication
Journal of Enzyme Inhibition and Medicinal Chemistry
Medicine
Drug Discovery
Pharmacology
Biological Evaluation of Inhibitors of Reverse Transcriptase From HIV Type-1
Current Chemistry Letters
Chemistry
FEP-Guided Selection of Bicyclic Heterocycles in Lead Optimization for Non-Nucleoside Inhibitors of HIV-1 Reverse Transcriptase
